Abstract
Subjects who are heterozygous for thyroid stimulating hormone receptor (TSHR) gene mutations present various phenotypes that range from euthyroid to hyperthyrotropinemia. Similarly, heterozygous dual oxidase 2 (DUOX2) gene mutations result in variable phenotypes, such as transient congenital hypothyroidism, subclinical hyperthyrotropinemia, and euthyroid in children. Here, we describe an 8-year-old boy who had normal newborn screening results, but who developed nonautoimmune hypothyroidism at the age of 1 year and 8 months of age. He was heterozygous for previously reported R450H-TSHR mutation and heterozygous for a novel double mutant allele A1323T-DUOX2 and L1343F-DUOX2. He needed levothyroxine (l-T4) replacement therapy to keep serum TSH levels within normal limits; l-T4 dose of 2.01–2.65 μg/kg/day corresponded to the dose taken by children homozygous for R450H-TSHR and by children with permanent congenital hypothyroidism. Therefore, the coexistence of a heterozygous TSHR mutation and a heterozygous DUOX2 mutation may have affected the severity of his hypothyroid condition.
References
1. Alberti L, Proverbio MC, Costagliola S, Romoli R, Boldrighini B, et al. Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. J Clin Endocrinol Metab 2002;87:2549–55.10.1210/jcem.87.6.8536Search in Google Scholar
2. Camilot M, Teofoli F, Gandini A, Franceschi R, Rapa A, et al. Thyrotropin receptor gene mutations and TSH resistance: variable expressivity in the heterozygous. Clin Endocrinol (Oxf) 2005;63:146–51.10.1111/j.1365-2265.2005.02314.xSearch in Google Scholar
3. Kanda K, Mizuno H, Sugiyama Y, Imamine H, Togari H, et al. Clinical significance of heterozygous carriers associated with compensated hypothyroidism in R450H, a common inactivating mutation of the thyrotropin receptor gene in Japanese. Endocrine 2006;30:383–8.10.1007/s12020-006-0018-zSearch in Google Scholar
4. Tonacchera M, Di Cosmo C, De Marco G, Agretti P, Banco M, et al. Identification of TSH receptor mutations in three families with resistance to TSH. Clin Endocrinol (Oxf) 2007;67:712–8.10.1111/j.1365-2265.2007.02950.xSearch in Google Scholar
5. Calebiro D, Gelmini G, Cordella D, Bonomi M, Winkler F, et al. Frequent TSH receptor genetic alterations with variable signaling impairment in a large series of children with nonautoimmune isolated hyperthyrotropinemia. J Clin Endocrinol Metab 2012;97:E156–60.10.1210/jc.2011-1938Search in Google Scholar
6. Niu DM, Lin CY, Hwang B, Jap TS, Liao CJ, et al. Contribution of genetic factors to neonatal transient hypothyroidism. Arc Dis Child Fetal Neonatal Ed 2005;90:F69–72.10.1136/adc.2003.039065Search in Google Scholar
7. Avbelj M, Tahirovic H, Debeljak M, Kusekova M, Toromanovic A, et al. High prevalence of thyroid peroxidase gene mutations in patients with thyroid dyshormonogenesis. Eur J Endorinol 2007;156:511–9.10.1530/EJE-07-0037Search in Google Scholar
8. De Marco G, Agretti P, Montanelli L, Di Cosmo C, Bagattini B, et al. Identification and functional analysis of novel dual oxidase 2 (DUOX2) mutations in children with congenital or subclinical hypothyroidism. J Clin Endocrinol Metab 2011;96:E1335–9.10.1210/jc.2010-2467Search in Google Scholar
9. De Roux N, Misrahi M, Chatelain N, Gross B, Milgrom E. Microsatellites and PCR primers for genetic studies and genomic sequencing of the human TSH receptor gene. Mol Cell Endocrinol 1996;117:253–6.10.1016/0303-7207(95)03753-5Search in Google Scholar
10. Park SM, Clifton-Bligh RJ, Betts P, Chatterjee VK. Congenital hypothyroidism and apparent athyreosis with compound heterozygosity or compensated hypothyroidism with probable hemizygosity for inactivating mutations of the TSH receptor. Clin Endocrinol (Oxf) 2004;60:220–7.10.1111/j.1365-2265.2004.01967.xSearch in Google Scholar PubMed
11. Kotani T, Umeki K, Yamamoto I, Ohtai S, Adachi M, et al. Iodide organification defects resulting from cosegregation of mutated and null thyroid peroxidase alleles. Mol Cell Endocrinol 2001;182:61–8.10.1016/S0303-7207(01)00547-0Search in Google Scholar
12. Moreno JC, Bikker H, Kempers MJ, van Trotsenburg AS, Baas F, et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002;347:95–102.10.1056/NEJMoa012752Search in Google Scholar PubMed
13. Nagashima T, Murakami M, Onigata K, Morimura T, Nagashima K, et al. Novel inactivating missense mutations in the thyrotropin receptor gene in Japanese children with resistance to thyrotropin. Thyroid 2001;11:551–9.10.1089/105072501750302859Search in Google Scholar PubMed
14. Narumi S, Muroya K, Abe Y, Yasui M, Asakura Y, et al. TSHR mutations as a cause of congenital hypothyroidism in Japan: a population-based genetic epidemiology study. J Clin Endocrinol Metab 2009;94:1317–23.10.1210/jc.2008-1767Search in Google Scholar PubMed
15. Rabbiosi S, Vigone MC, Cortinovis F, Zamproni I, Fugazzola L, et al. Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J Clin Endocrinol Metab 2013;98:1395–402.10.1210/jc.2012-3174Search in Google Scholar PubMed
16. Badano JL, Kim JC, Hoskins BE, Lewis RA, Ansley SJ, et al. Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. Hum Mol Genet 2003;12:1651–9.10.1093/hmg/ddg188Search in Google Scholar PubMed
17. Hoefele J, Wolf MT, O’Toole JF, Otto EA, Schultheiss U, et al. Evidence of oligogenic inheritance in nephronophthisis. J Am Soc Nephrol 2007;18:2789–95.10.1681/ASN.2007020243Search in Google Scholar PubMed
18. Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci USA 2010;107:15140–4.10.1073/pnas.1009622107Search in Google Scholar PubMed PubMed Central
19. Sriphrapradang C, Tenenbaum-Rakover Y, Weiss M, Barkoff MS, Admoni O, et al. The coexistence of a novel inactivating mutant thyrotropin receptor allele with two thyroid peroxidase mutations: a genotype-phenotype correlation. J Clin Endocrinol Metab 2011;96:E1001–6.10.1210/jc.2011-0127Search in Google Scholar PubMed PubMed Central
20. Riguto S, Hoste C, Grasberger H, Milenkovic M, Communi D, et al. Activation of dual oxidase Duox 1 and Duox 2: differential regulation mediated by cAMP-dependent protein kinase and protein kinase C-dependent phospholylation. J Biol Chem 2009;284:6725–34.Search in Google Scholar
21. Narumi S, Nagasaki K, Ishii T, Muroya K, Asakura Y, et al. Nonclassic TSH resistance: TSHR mutation carriers with discrepantly high thyroid iodine uptake. J Clin Endocrinol Metab 2011;96:E1340–5.10.1210/jc.2011-0070Search in Google Scholar PubMed
22. Tonacchera M, De Marco G, Agretti P, Montanelli L, Di Cosmo C, et al. Identification and functional studies of two new dual-oxidase 2 (DUOX2) mutations in a child with congenital hypothyroidism and a eutopic normal-size thyroid gland. J Clin Endocrinol Metab 2009;94:4309–14.10.1210/jc.2009-0426Search in Google Scholar PubMed
23. Yoshizawa-Ogasawara A, Ogikubo S, Satoh M, Narumi S, Hasegwa T. Congenital hypothyroidism caused by a novel mutation of the dual oxidase 2 (DUOX2) gene. J Pediatr Endocrnol Metab 2013;26:45–52.10.1515/jpem-2012-0082Search in Google Scholar PubMed
24. Ohye H, Fukata S, Hishinuma A, Kudo T, Nishihara E, et al. A novel homozygous missense mutation of the dual oxidase 2 (DUOX2) gene in an adult patient with large goier. Thyroid 2008;18:561–6.10.1089/thy.2007.0258Search in Google Scholar PubMed
©2015 by De Gruyter
